WATERTOWN, Massachusetts (GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a...
EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of EYP-1901 for the Treatment of Wet AMD
read more
detail
EW Healthcare Partners Announces the Closing of EW Healthcare Partners Acquisition Fund with Bioventus as the Core Holding
New York, NY –– EW Healthcare Partners (“EW”), a private equity firm dedicated to making growth...
Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio
BOSTON, Massachusetts—PRNewswire—Haemonetics Corporation (NYSE: HAE) (“Haemonetics”), a global...
Cardiva Medical Announces $45 Million Financing Led by EW Healthcare Partners
Robert S. White Joins Board of Directors SANTA CLARA, California (GLOBE NEWSWIRE)—Cardiva Medical,...
MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings
Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital...
Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Providing large scale manufacturing capacity for AZD1222 Keele, UK, 16 June 2020: Cobra Biologics...
Xenex LightStrike Robot Destroys SARS-CoV-2 (Coronavirus) in 2 Minutes; First & Only UV Disinfection Technology Proven to Deactivate COVID-19 Virus
San Antonio – April 30, 2020 — SARS-CoV-2 is a global threat for which the world was unprepared....
EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Watertown, MASSACHUSETTS—(GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a...
Cognate BioServices closes Series B and completes acquisition of Cobra Biologics
MEMPHIS, Tennessee—Cognate BioServices, a leading contract development and manufacturing...
Sonendo® Announces Growth Investment from EW Healthcare Partners
Leading Dental Technology Company Raises $85 Million to Accelerate Growth LAGUNA HILLS,...